<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6897</article-id>
      <article-id pub-id-type="doi">10.51847/v4xb0YLxhw</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Predicting Vaccine Cold-Chain Failure Using Temperature Streams, Packaging, Route, and Excursion History</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Boateng</surname>
                <given-names>Samuel</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Mensah</surname>
                <given-names>Kwesi</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Asante</surname>
                <given-names>Kojo</given-names>
              </name>
                              <xref rid="aff2" ref-type="aff">2</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Owusu</surname>
                <given-names>Linda</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of AI-Based Pharmaceutical Sciences, Faculty of Pharmacy, University of Ghana, Accra, Ghana.
          </aff>
                  <aff id="aff2">
            <label>2</label>Department of Computational Pharmacology, Faculty of Medicine, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="samuel.boateng@gmail.com">samuel.boateng@gmail.com</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>28</day>
        <month>04</month>
        <year>2026</year>
      </pub-date>
      <volume>17</volume>
      <issue>2</issue>
      <fpage>112</fpage>
      <lpage>122</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Vaccines can lose potency when exposed to temperatures outside their specified storage range, and cold-chain failures may compromise immunization programs even if discovered only after delivery. Most monitoring systems react after a temperature threshold has already been crossed, limiting opportunities for re-cooling, rerouting, or shipment replacement before product integrity is threatened. To address this, a predictive machine learning model is proposed to estimate the probability of vaccine cold-chain failure before an excursion occurs, integrating streaming temperature data, packaging insulation characteristics, route conditions, and the shipment or container’s excursion history. Using a gradient-boosted classification framework applied to historical shipment records and continuously updated sensor feeds, the model considers features such as temperature trends, variability, packaging configuration, phase-change material properties, expected route exposure, and prior excursion severity. By identifying shipments whose thermal conditions are becoming unstable before formal failure thresholds are crossed, the model can support targeted interventions, including expedited transfer, additional cooling at hand-off points, or pre-release quality review. Predictive cold-chain analytics have the potential to shift vaccine logistics from retrospective excursion documentation to proactive risk management, reducing wastage, enhancing supply-chain resilience, and safeguarding the integrity of vaccination programs.</p>
      </abstract>
      <kwd-group>
                <kwd>Vaccine cold chain</kwd>
                <kwd>Predictive analytics</kwd>
                <kwd>Temperature excursion</kwd>
                <kwd>Machine learning</kwd>
                <kwd>IoT monitoring</kwd>
                <kwd>Phase-change materials</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>